Skip to main content

CORRECTION article

Front. Pharmacol., 02 November 2022
Sec. Translational Pharmacology
Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.1073618

Corrigendum: Adenosine receptor stimulation improves glucocorticoid-induced osteoporosis in a rat model

This article is a correction to:

  1. Adenosine Receptor Stimulation Improves Glucocorticoid-Induced Osteoporosis in a Rat Model

    1. Read original article
Gabriele PizzinoGabriele Pizzino1Natasha IrreraNatasha Irrera1Federica GalfoFederica Galfo1Giacomo OteriGiacomo Oteri2Marco AtteritanoMarco Atteritano1Giovanni PallioGiovanni Pallio1Federica ManninoFederica Mannino1Angelica D&#x;AmoreAngelica D’Amore1Enrica PellegrinoEnrica Pellegrino1Federica AliquFederica Aliquò1Giuseppe P. AnastasiGiuseppe P. Anastasi2Giuseppina CutroneoGiuseppina Cutroneo1Francesco SquadritoFrancesco Squadrito1Domenica AltavillaDomenica Altavilla2Alessandra Bitto Alessandra Bitto1*
  • 1Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy
  • 2Department of Biomedical Sciences, Dentistry, Morphological and Functional Images, University of Messina, Messina, Italy

A Corrigendum on
Adenosine receptor stimulation improves glucocorticoid-induced osteoporosis in a rat model

by Pizzino G, Irrera N, Galfo F, Oteri G, Atteritano M, Pallio G, Mannino F, D’Amore A, Pellegrino E, Aliquò F, Anastasi GP, Cutroneo G, Squadrito F, Altavilla D and Bitto A (2017). Front. Pharmacol. 8:558. doi: 10.3389/fphar.2017.00558

In the published article, the Conflict of Interest statement was incorrectly filed. The correct Conflict of Interest statement appears below.

“Author FS has received research support from Mastelli for work on polydeoxyribonucleotide. Authors FS, AB and DA are co‐inventors on a patent describing therapeutic polydeoxyribonucleotide activity in chronic intestinal disease. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: PDRN, Adenosine, glucocorticoids, osteoporosis, rats

Citation: Pizzino G, Irrera N, Galfo F, Oteri G, Atteritano M, Pallio G, Mannino F, D’Amore A, Pellegrino E, Aliquò F, Anastasi GP, Cutroneo G, Squadrito F, Altavilla D and Bitto A (2022) Corrigendum: Adenosine receptor stimulation improves glucocorticoid-induced osteoporosis in a rat model. Front. Pharmacol. 13:1073618. doi: 10.3389/fphar.2022.1073618

Received: 18 October 2022; Accepted: 19 October 2022;
Published: 02 November 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Pizzino, Irrera, Galfo, Oteri, Atteritano, Pallio, Mannino, D’Amore, Pellegrino, Aliquò, Anastasi, Cutroneo, Squadrito, Altavilla and Bitto. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Alessandra Bitto, abitto@unime.it

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.